Pearl Pathways is a leading consultancy in the life science industry, focusing on regulatory, quality compliance, and clinical services for biopharmaceutical, medical device, and diagnostic companies. Established in 2010 and headquartered in Indianapolis, IN, Pearl Pathways is committed to accelerating life science product development for its clients. Their expertise lies in providing strategic guidance and project-based support, leveraging their team's extensive experience in clinical, scientific, industry, FDA, and global regulatory authority. Pearl Pathways is distinguished as a trusted advisor and preferred partner for innovative and expedited life science product development, helping clients navigate the complex regulatory landscape while balancing risk, speed to market, and cost. Additionally, the company supports human research through its full-service central independent review board, Pearl IRB. Notably, Pearl Pathways is a certified Women’s Business Enterprise, reflecting its commitment to diversity and inclusion. With its tailored solutions, Pearl Pathways enables emerging to mid-size life science companies to bring vital products to the market efficiently. While specific details about the most recent investment and investors are not available, the company's robust positioning and impactful contributions within the Biotechnology, Health Care, Medical Devices, and Pharmaceutical industries indicate its potential for continued growth and success.
There is no investment information
No recent news or press coverage available for Pearl Pathways.